Physician Preferences for Nonmetastatic Castration-Resistant Prostate Cancer Treatment in China
Frontiers in Oncology（2024）
Key words
nonmetastatic castration-resistant prostate cancer (nmCRPC),second-generation androgen receptor inhibitors (SGARIs),choice behavior,quality of life,physicians
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined